Paper- New Variants better at trying to evade cel
Post# of 36536
(Total Views: 347)
Posted On: 07/21/2021 2:32:39 PM
Paper- New Variants better at trying to evade cellular immunity in asian predominant HLA allel
https://www.cell.com/cell-host-microbe/fullte...all%3Dtrue
Yes, we say and believe in 'having the technology for the so called Complet Vaccine.......yet to be proven that fabulous.
(Too early, ....and too confident for such a benchmark-to-be expression)
(I'm with those who stress the immense oppotunity and challenge to get through all the necesary procedures ---time and money consuming, not to mention stockholders patience---so to offer a shift in the paradigm of treating diseases like covid((all in all mRNA technology took advantage of this 'convinient' pqndemic, emertency approval, barda ....and thousands of voluntary people as well as medical staff tor trials to get it to a completion)
We need to open THIS door....and afterwards we'll see how well it matches with whatever immunitary-mediated approach we may think of for so many prevalent diseases ...by.'merely' adjusting and confronting each
It is a race with all-perfect only, for the homerun. Just one step disappointing or 'not-complet', qnd we'll get stuck (with dozens and dozens of other promisig runners lost 'in translational phases
(Sorry for my english)
https://www.cell.com/cell-host-microbe/fullte...all%3Dtrue
Yes, we say and believe in 'having the technology for the so called Complet Vaccine.......yet to be proven that fabulous.
(Too early, ....and too confident for such a benchmark-to-be expression)
(I'm with those who stress the immense oppotunity and challenge to get through all the necesary procedures ---time and money consuming, not to mention stockholders patience---so to offer a shift in the paradigm of treating diseases like covid((all in all mRNA technology took advantage of this 'convinient' pqndemic, emertency approval, barda ....and thousands of voluntary people as well as medical staff tor trials to get it to a completion)
We need to open THIS door....and afterwards we'll see how well it matches with whatever immunitary-mediated approach we may think of for so many prevalent diseases ...by.'merely' adjusting and confronting each
It is a race with all-perfect only, for the homerun. Just one step disappointing or 'not-complet', qnd we'll get stuck (with dozens and dozens of other promisig runners lost 'in translational phases
(Sorry for my english)
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼